North America Cellulite Treatment Market 2023-2030

North America Cellulite Treatment Market 2023-2030



Market Outlook

Triton Market Research’s report reckons that the cellulite treatment market in North America is set to advance with a compound annual growth rate of 9.58% over the forecasting years 2023-2030. Canada and the United States are gauged in the region.

The high prevalence of obesity is expected to drive the market’s growth in Canada. As per estimates, the number of people diagnosed with obesity is expected to rise owing to unhealthy lifestyle choices. This will further elevate the demand for cosmetic procedures to enhance appearance. Moreover, the increase in the geriatric population has also surged the demand for aesthetic treatments like cellulite reduction. In this regard, non-invasive and minimally invasive treatments have significantly backed the expansion of the cellulite treatment market.

Likewise, the high obesity rates have compelled people to opt for various treatments in the US. The availability of minimally invasive procedures has significantly increased the number of patients opting for cellulite treatments. Hence, the growing beauty consciousness and advanced treatments widen the overall scope and growth of the cellulite treatment market across the United States.

Competitive Outlook

The established companies in the cellulite treatment market consist of AbbVie Inc, Bausch Health Companies Inc, Johnson & Johnson, Galderma SA, and Endo International Plc.


1. North America Cellulite Treatment Market - Summary
2. Industry Outlook
2.1. Parent Market Analysis
2.2. Impact Analysis On The Cellulite Treatment Market
2.2.1. Covid-19 Impact On The Cellulite Treatment Market
2.2.2. Ukraine-russia War Impact On The Cellulite Treatment Market
2.3. Porter’s Five Forces Analysis
2.3.1. Threat Of New Entrants
2.3.2. Threat Of Substitutes
2.3.3. Bargaining Power Of Buyers
2.3.4. Bargaining Power Of Suppliers
2.3.5. Threat Of Competitive Rivalry
2.4. Market Maturity Analysis
2.5. Industry Components
2.5.1. Research And Development
2.5.2. Manufacturing Of Product
2.5.3. Distribution
2.5.4. Post-sales Monitoring
2.6. Regulatory Framework
2.7. Key Buying Impact Analysis
2.7.1. Price
2.7.2. Brand Name
2.7.3. Usability
2.8. Key Market Strategies
2.8.1. Collaborations
2.8.2. Product Launches
2.8.3. Mergers & Acquisitions
2.8.4. Business Divestitures & Expansions
2.9. Market Drivers
2.9.1. Growing Prevalence Of Obesity
2.9.2. Rapidly Growing Medical Tourism Sector
2.9.3. Rising Demand For Aesthetic Procedures
2.10. Market Challenges
2.10.1. Lack Of Knowledge Regarding Cellulite Treatment
2.10.2. High Price Of Advanced Cellulite Treatment
2.10.3. Risks Associated Post-treatment
2.11. Market Opportunities
2.11.1. Rising Beauty Consciousness
2.11.2. Increasing Trend Of Anti-cellulite Massage
2.11.3. Growing Demand For Minimally Invasive And Non-invasive Procedures
2.11.4. Rising Popularity Of Radiofrequency Therapy For Cellulite Treatment
2.11.5. Advancements In Technologies And New Product Launches
2.12. Analyst Perspective
3. North America Cellulite Treatment Market – By Cellulite Type
3.1. Soft Cellulite
3.2. Hard Cellulite
3.3. Edematous Cellulite
4. North America Cellulite Treatment Market – By Procedure Type
4.1. Non-invasive
4.2. Minimally Invasive
4.3. Topical
5. North America Cellulite Treatment Market – By End-user
5.1. Hospitals
5.2. Clinics And Beauty Centers
5.3. Other End-users
6. North America Cellulite Treatment Market – By Country Outlook
6.1. Country Analysis
6.1.1. United States
6.1.1.1. United States Cellulite Treatment Market Forecast & Prospects
6.1.2. Canada
6.1.2.1. Canada Cellulite Treatment Market Forecast & Prospects
7. Competitive Landscape
7.1. Johnson & Johnson
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Key Strengths
7.1.4. Key Challenges
7.2. Abbvie Inc
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Key Strengths
7.2.4. Key Challenges
7.3. Bausch Health Companies Inc
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Key Strengths
7.3.4. Key Challenges
7.4. Cutera Inc
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Key Strengths
7.4.4. Key Challenges
7.5. Inceler Medikal
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Key Strengths
7.5.4. Key Challenges
7.6. Zimmer Medizinsysteme Gmbh
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Key Strengths
7.6.4. Key Challenges
7.7. Galderma Sa
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Key Strengths
7.7.4. Key Challenges
7.8. Sientra Inc
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Key Strengths
7.8.4. Key Challenges
7.9. Endo International Plc
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Key Strengths
7.9.4. Key Challenges
7.10. Candela Medical Corporation
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Key Strengths
7.10.4. Key Challenges
8. Research Methodology & Scope
8.1. Research Scope & Deliverables
8.1.1. Objectives Of Study
8.1.2. Scope Of Study
8.2. Sources Of Data
8.2.1. Primary Data Sources
8.2.2. Secondary Data Sources
8.3. Research Methodology
8.3.1. Evaluation Of The Proposed Market
8.3.2. Identification Of Data Sources
8.3.3. Assessment Of Market Determinants
8.3.4. Data Collection
8.3.5. Data Validation & Analysis
Table List
Table 1: North America Cellulite Treatment Market, By Country Outlook, 2023-2030 (In $ Million)
Table 2: Regulatory Framework
Table 3: List Of Collaborations
Table 4: List Of Product Launches
Table 5: List Of Mergers & Acquisitions
Table 6: List Of Business Divestitures & Expansions
Table 7: North America Cellulite Treatment Market, By Cellulite Type, 2023-2030 (In $ Million)
Table 8: North America Cellulite Treatment Market, By Procedure Type, 2023-2030 (In $ Million)
Table 9: North America Cellulite Treatment Market, By End-user, 2023-2030 (In $ Million)
Table 10: North America Cellulite Treatment Market, By Country Outlook, 2023-2030 (In $ Million)
Figure List
Figure 1: Market Maturity Analysis
Figure 2: Industry Components
Figure 3: Key Buying Impact Analysis
Figure 4: North America Cellulite Treatment Market, By Cellulite Type, 2022 & 2030 (In %)
Figure 5: North America Cellulite Treatment Market, By Soft Cellulite, 2023-2030 (In $ Million)
Figure 6: North America Cellulite Treatment Market, By Hard Cellulite, 2023-2030 (In $ Million)
Figure 7: North America Cellulite Treatment Market, By Procedure Type, 2022 & 2030 (In %)
Figure 8: North America Cellulite Treatment Market, By Non-invasive, 2023-2030 (In $ Million)
Figure 9: North America Cellulite Treatment Market, By Minimally Invasive, 2023-2030 (In $ Million)
Figure 10: North America Cellulite Treatment Market, By Topical, 2023-2030 (In $ Million)
Figure 11: North America Cellulite Treatment Market, By End-user, 2022 & 2030 (In %)
Figure 12: North America Cellulite Treatment Market, By Hospitals, 2023-2030 (In $ Million)
Figure 13: North America Cellulite Treatment Market, By Clinics And Beauty Centers, 2023-2030 (In $ Million)
Figure 14: North America Cellulite Treatment Market, By Other End-users, 2023-2030 (In $ Million)
Figure 15: North America Cellulite Treatment Market, By Country Outlook, 2022 & 2030 (In %)
Figure 16: United States Cellulite Treatment Market 2023-2030 (In $ Million)
Figure 17: Canada Cellulite Treatment Market 2023-2030 (In $ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings